BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27756620)

  • 1. Virulence arsenal of the most pathogenic species among the Gram-positive anaerobic cocci, Finegoldia magna.
    Boyanova L; Markovska R; Mitov I
    Anaerobe; 2016 Dec; 42():145-151. PubMed ID: 27756620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pili on the surface of Finegoldia magna--a gram-positive anaerobic cocci.
    Murphy EC; Janulczyk R; Karlsson C; Mörgelin M; Frick IM
    Anaerobe; 2014 Jun; 27():40-9. PubMed ID: 24685556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-positive anaerobic cocci--commensals and opportunistic pathogens.
    Murphy EC; Frick IM
    FEMS Microbiol Rev; 2013 Jul; 37(4):520-53. PubMed ID: 23030831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finegoldia magna Isolated from Orthopedic Joint Implant-Associated Infections.
    Söderquist B; Björklund S; Hellmark B; Jensen A; Brüggemann H
    J Clin Microbiol; 2017 Nov; 55(11):3283-3291. PubMed ID: 28904182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-genome analysis of the genus Finegoldia identifies two distinct clades, strain-specific heterogeneity, and putative virulence factors.
    Brüggemann H; Jensen A; Nazipi S; Aslan H; Meyer RL; Poehlein A; Brzuszkiewicz E; Al-Zeer MA; Brinkmann V; Söderquist B
    Sci Rep; 2018 Jan; 8(1):266. PubMed ID: 29321635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological features of bacteraemia with Gram-positive anaerobic cocci: a population-based retrospective study.
    Badri M; Nilson B; Ragnarsson S; Senneby E; Rasmussen M
    Clin Microbiol Infect; 2019 Jun; 25(6):760.e1-760.e6. PubMed ID: 30217761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroimidazole resistance genes (nimB) in anaerobic Gram-positive cocci (previously Peptostreptococcus spp.).
    Theron MM; Janse Van Rensburg MN; Chalkley LJ
    J Antimicrob Chemother; 2004 Jul; 54(1):240-2. PubMed ID: 15150170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SufA--a novel subtilisin-like serine proteinase of Finegoldia magna.
    Karlsson C; Andersson ML; Collin M; Schmidtchen A; Björck L; Frick IM
    Microbiology (Reading); 2007 Dec; 153(Pt 12):4208-4218. PubMed ID: 18048934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.
    Claros M; Citron DM; Goldstein EJ; Merriam CV; Tyrrell KL
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):546-8. PubMed ID: 23727512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding antimicrobial susceptibility profile of Finegoldia magna: an insight to an untrodden path.
    Shetty S; Anegundi R; Shenoy PA; Vishwanath S
    Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):30. PubMed ID: 37098571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of pacemaker pocket infection caused by Finegoldia magna.
    Hosseini Dehkordi SH; Osorio G
    Anaerobe; 2017 Oct; 47():135-136. PubMed ID: 28552416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast abscess due to Finegoldia magna in a non-puerperal women.
    Cobo F; Rodríguez-Granger J; Sampedro A; Navarro-Marí JM
    Anaerobe; 2017 Oct; 47():183-184. PubMed ID: 28583865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci.
    Kreikemeyer B; Gámez G; Margarit I; Giard JC; Hammerschmidt S; Hartke A; Podbielski A
    Int J Med Microbiol; 2011 Mar; 301(3):240-51. PubMed ID: 21112248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of molecular mechanisms used by Finegoldia magna to penetrate and colonize human skin.
    Murphy EC; Mörgelin M; Reinhardt DP; Olin AI; Björck L; Frick IM
    Mol Microbiol; 2014 Oct; 94(2):403-17. PubMed ID: 25164331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.
    Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE;
    Int J Antimicrob Agents; 2008 Apr; 31(4):316-20. PubMed ID: 18180149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of clinically relevant Gram-positive anaerobic cocci collected over a three-year period in the Netherlands.
    Veloo AC; Welling GW; Degener JE
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1199-203. PubMed ID: 21189338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nonpuerperal breast abscess caused by Finegoldia magna].
    Castello L; Bou M; Bazzana MS; Predari SC
    Rev Argent Microbiol; 2007; 39(2):95-8. PubMed ID: 17702255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation.
    Karlsson C; Mörgelin M; Collin M; Lood R; Andersson ML; Schmidtchen A; Björck L; Frick IM
    Microbiology (Reading); 2009 Jan; 155(Pt 1):238-248. PubMed ID: 19118364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-positive anaerobic cocci.
    Murdoch DA
    Clin Microbiol Rev; 1998 Jan; 11(1):81-120. PubMed ID: 9457430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SufA of the opportunistic pathogen finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.
    Karlsson C; Eliasson M; Olin AI; Mörgelin M; Karlsson A; Malmsten M; Egesten A; Frick IM
    J Biol Chem; 2009 Oct; 284(43):29499-508. PubMed ID: 19628464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.